Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia

European Journal of Cancer Prevention

Volumn 20, Issue 1, 2011, Pages 33-39

  Dondog, Bolormaa ^a   Lise, Mauro ^b   Dondov, Oyunchimeg ^c   Baldandorj, Baigal ^d   Franceschi, Silvia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c National Cancer Center of Mongolia   (Mongolia)

^d Ministry of Health   (Mongolia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONGOLIA; PRIORITY JOURNAL; SEROPREVALENCE;

ADULT; AGE DISTRIBUTION; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MONGOLIA; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS;

EID: 78650475014     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32833f0c8e     Document Type: Article

References (16)

1. Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. (2007). Carcinogenicity of alcoholic beverages. Lancet Oncol 8: 292-293.
2. But DY, Lai CL, Yuen MF (2008). Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol 14:1652-1656.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr.
4. IARC (2004). Monographs on the evaluation of carcinogenic risks to humans volume 83: Tobacco smoke and involuntary smoking. Lyon: IARC Press.
5. Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ, et al. (2004). The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 39: 211-219.
6. Kurbanov F, Tanaka Y, Elkady A, Oyunsuren T, Mizokami M (2007). Tracing hepatitis C and delta viruses to estimate their contribution in HCC rates in Mongolia. J Viral Hepat 14:667-674.
7. Logez S, Soyolgerel G, Fields R, Luby S, Hutin Y (2004). Rapid assessment of injection practices in Mongolia. Am J Infect Control 32:31-37.
8. Muhlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U (2009). HCV-related burden of disease in Europe: A systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 9:34.
9. National Statistical Office of Mongolia (2007). Mongolian statistical yearbook 2006. Ulaanbaatar: National Statistical Office of Mongolia.
10. Oyunsuren T, Kurbanov F, Tanaka Y, Elkady A, Sanduijav R, Khajidsuren O, et al. (2006). High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses. J Med Virol 78:1688-1695.
11. Parkin DM (2006). The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030-3044.
12. Raza SA, Clifford GM, Franceschi S (2007). Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: A systematic review. Br J Cancer 96:1127-1134.
13. Schuppan D, Afdhal NH (2008). Liver cirrhosis. Lancet 371:838-851.
14. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006). Hepatitis B virus infection: Epidemiology and vaccination. Epidemiol Rev 28: 112-125.
15. Tserenpuntsag B, Ouynbileg L, Nelson K, McNutt LA (2008). Prevalence of infectious diseases among Mongolian blood donors. J Infect Dev Ctries 2:73-75.
16. Wild CP, Gong YY (2010). Mycotoxins and human disease: A largely ignored global health issue. Carcinogenesis 31:71-82.